P-sep

P-sep is a device for the collection of urine samples for clinical analysis.

P-sep is unique in that it allows the collection of both first-pass urine and mid-stream urine separately and at the same time; and without interruption to the flow of urine.

P-sep can be used with equal facility by male and female, young and old.

P-sep consists of three parts, the funnel, the ball and the tube.

Before use, the ball is placed in the tube and the funnel placed on the tube

A push and a click and P-sep is ready for use

(In the following demonstration the tube has been doped with a red dye)

Urine (in this case water) is passed into the funnel:

P-sep is now tilted to dispense the mid-stream urine into a container large enough to hold all the mid-stream urine

...and then further tilted to dispense the first pass- urine

The mid-stream urine is separated from the first-pass urine and is entirely free from first-pass urine

Both mid-stream and first pass urine are now ready for the laboratory.

P-sep (patent pending) is an invention from Knight Scientific LTD

15 Wolsely Close Business Park, PLYMOUTH, PL23BY

+44(0) 1752 56576 info@knightscientific.com

Knight Scientific exclusive world manufacturer of Pholasin® and ABEL kits. Leader in chemiluminescence and bioluminescence measurement of reactive oxygen species (ROS): superoxide, singlet oxygen, peroxynitrite, peroxyl radicals, hydroxyl radicals, halogenated oxidants. Oxidative stress, antioxidant tests against different ROS, unique ABEL-RAC method, measurement of viral and bacterial infections even without symptoms. Manage over training in human and equine sport. Measure urinary tract infections and sexually transmitted infections. 

 ABEL and Pholasin are registered trademarks of Knight Scientific Limited.

KNIGHT SCIENTIFIC LIMITED
15 Wolseley Close Business Park
Plymouth
PL2 3BY
United Kingdom


+44 (0) 1752 565 676
info@knightscientific.com
www.knightscientific.com

SupaSynergy.com
1402 Crabtree Drive

Vincennes, Indiana

USA

 

Tel: 1-828-506-6480
 

  • Twitter
  • LinkedIn